1. From the Institute of Cardiovascular Science and National Institute for Health Research Biomedical Research Centre, University College London, London, United Kingdom (B.W., P.S.L.); Novartis Clinical Development, Basel, Switzerland (F.B., P.B.); and Medizinische Universitäts-Poliklinik, Bonn, Germany (R.D.).